To investigate the role of iron overload in the mechanisms of bone destruction in pyogenic spondylitis (PS).
Approach:
Clinical Study: Vertebrae samples were collected from patients with PS to evaluate iron overload and TfR1 expression.
In Vivo and In Vitro Experiments: S. aureus was used to induce bone infection, and experiments were conducted to assess the effects of siRNA targeting TfR1, an iron chelator (DFO), and the TfR1 inhibitor Ferristatin II on iron overload and ferroptosis.
Key Findings:
Infected vertebral specimens showed iron overload and increased TfR1 expression.
Excessive iron led to osteoblast ferroptosis and impaired osteogenic activity.
Iron overload activated the cGAS/STING pathway, contributing to NLRP3-associated pyroptosis.
S. aureus-induced iron overload promoted osteoclastogenesis.
Ferristatin II reduced iron deposition and preserved trabecular architecture in PS rats.
Interpretation:
S. aureus infection leads to iron overload in infected bone tissue via TfR1, resulting in osteoblast ferroptosis and bone destruction.
Limitations:
The study primarily focuses on mechanisms in vitro and in animal models, which may not fully replicate human conditions.
Further clinical studies are necessary to validate the findings.
Conclusion:
The findings suggest that targeting TfR1-mediated iron influx and ferroptosis may be a potential area for future therapeutic exploration in treating bone loss associated with PS.
